Fosfomycin

The standard adult dosage for fosfomycin tromethamine in the treatment of uncomplicated urinary tract infections (acute cystitis) is a single 3-gram sachet. This is a one-time dose. Unlike most antibiotics where you must remember to take pills for 3, 7, or 10 days, fosfomycin is designed to work as a 'one-and-done' treatment because it stays in the bladder at high concentrations for several days.

For women 18 years of age and older, the dose is:

• Acute Cystitis: One 3-gram sachet mixed in water, taken orally once.

It is important to note that taking more than one dose for a single episode of acute cystitis does not improve the success rate and may increase the risk of side effects. If symptoms do not improve within 2 to 3 days after taking the dose, you should contact your healthcare provider.

Fosfomycin is currently approved for use in female adolescents who are 12 years of age and older for the treatment of uncomplicated UTIs. The dosage is the same as the adult dose:

• Adolescents (12-17 years): One 3-gram sachet mixed in water, taken orally once.

Fosfomycin is NOT recommended for children under the age of 12. The safety and effectiveness in this younger population have not been established in clinical trials. If a child under 12 has a UTI, a healthcare provider will typically choose an alternative antibiotic such as amoxicillin or a cephalosporin.

Renal Impairment

Because fosfomycin is primarily excreted by the kidneys, its clearance is reduced in patients with kidney disease. However, for the single-dose treatment of cystitis, no specific dose adjustment is usually required for patients with mild to moderate renal impairment. In patients with severe renal impairment (creatinine clearance < 10 mL/min) or those on hemodialysis, the drug is not effectively cleared into the urine, and its use is generally not recommended as it will not reach the necessary concentrations in the bladder to kill the bacteria.

Hepatic Impairment

Since fosfomycin is not metabolized by the liver, no dosage adjustments are necessary for patients with liver disease or hepatic impairment.

Elderly Patients

Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased renal function. However, the standard 3-gram dose is typically used unless severe renal failure is present.

Proper administration is key to ensuring the drug works correctly:

1. 1Preparation: Do not take the powder dry. Open the sachet and pour the entire contents into a glass containing approximately 3 to 4 ounces (90 to 120 mL) of water.
2. 2Mixing: Stir the powder into the water until it dissolves. Do not use hot water; use room temperature or cold water.
3. 3Timing: Drink the entire mixture immediately after preparation. It is best taken on an empty stomach (either 1 hour before or 2 hours after a meal) to ensure maximum absorption. Many doctors recommend taking it before bed after emptying your bladder, so the medicine can stay in the bladder at high concentrations overnight.
4. 4Food: While it can be taken with food if necessary for stomach comfort, be aware that food significantly slows down how quickly the drug reaches your system.

Since fosfomycin is a single-dose treatment, 'missing' a dose is rare. However, if your doctor has prescribed it and you forget to take it, take it as soon as you remember. If you were supposed to take it before bed and forgot, take it the next morning on an empty stomach. Do not take two doses to 'make up' for the delay.

Overdose with oral fosfomycin is extremely rare due to the single-dose packaging. However, if someone accidentally ingests multiple sachets, symptoms may include vestibular loss (balance issues), impaired hearing, a metallic taste in the mouth, and general digestive upset.

Emergency Measures:

• If an overdose is suspected, contact a Poison Control Center or seek emergency medical care immediately.
• Treatment is usually supportive (treating the symptoms).
• Drinking plenty of water can help encourage the elimination of the drug through the urine.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or share this medication with others without medical guidance.

Fosfomycin is generally well-tolerated, but like all medications, it can cause side effects. Because it is a single-dose treatment, side effects are usually short-lived. The most common side effects reported in clinical trials include:

• Diarrhea: This is the most frequently reported side effect, occurring in about 10-12% of patients. It is usually mild and self-limiting. It occurs because the antibiotic can disrupt the normal balance of bacteria in the gut.
• Nausea: Some patients (about 4%) report feeling slightly sick to their stomach shortly after taking the dose. This usually passes within a few hours.
• Headache: Reported by approximately 4% of users. It is typically mild and can be managed with over-the-counter pain relief if approved by a doctor.
• Vaginitis: In women, antibiotics can sometimes lead to a secondary yeast infection (candidiasis) because the drug kills the 'good' bacteria that keep yeast in check. Symptoms include itching, redness, and unusual discharge.

These effects occur in 1% to 10% of the population:

• Dizziness: Some patients may feel lightheaded or unsteady. It is advised not to drive or operate machinery until you know how the drug affects you.
• Abdominal Pain: Cramping or general discomfort in the stomach area.
• Dyspepsia: Indigestion or a feeling of fullness after taking the medication.
• Weakness (Asthenia): A general feeling of tiredness or lack of energy.

These effects are very uncommon but have been documented:

• Skin Rash: A mild, itchy red rash or hives (urticaria).
• Anorexia: A temporary loss of appetite.
• Somnolence: Excessive sleepiness or drowsiness.
• Visual Disturbances: Blurred vision or minor changes in sight.

While rare, some side effects require urgent medical intervention.

> Warning: Stop taking Fosfomycin and call your doctor immediately if you experience any of the following:

1. 1Anaphylaxis (Severe Allergic Reaction): Symptoms include swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; a rapid heartbeat; and a severe, widespread skin rash. This is a medical emergency.
2. 2Clostridioides difficile-Associated Diarrhea (CDAD): This can occur with almost any antibiotic. It happens when the drug kills off too many healthy gut bacteria, allowing C. diff to overgrow. Symptoms include severe watery diarrhea (at least 3 loose stools per day for two or more days), bloody stools, and intense stomach cramping. This can occur even weeks after the dose is taken.
3. 3Hepatotoxicity: Although extremely rare with a single dose, signs of liver trouble include yellowing of the skin or eyes (jaundice), dark urine, and upper right-side stomach pain.
4. 4Superinfection: If you notice new symptoms of infection (like fever or worsening pain) after taking the drug, it may mean a different type of bacteria or fungus that is resistant to fosfomycin is growing.

Because fosfomycin is typically used as a single-dose therapy for acute infections, long-term side effects are not a standard concern. However, repeated use of the drug for recurrent UTIs can potentially lead to:

• Antibiotic Resistance: Bacteria may evolve to become resistant to fosfomycin if it is used too frequently or inappropriately.
• Chronic Gut Dysbiosis: Repeated disruption of the gut microbiome, though this is less likely with fosfomycin than with long courses of other antibiotics.

As of 2026, there are no FDA black box warnings for fosfomycin tromethamine. It is considered a safe and effective medication when used as directed for its approved indications.

Report any unusual symptoms to your healthcare provider. If you experience persistent diarrhea, even weeks after your dose, do not use anti-diarrheal products like loperamide without consulting a doctor, as these can make certain infections (like C. diff) worse.

Fosfomycin is intended only for the treatment of uncomplicated urinary tract infections (cystitis). It is not effective for more complicated infections, such as pyelonephritis (kidney infection) or perinephric abscesses. If you have symptoms such as high fever, chills, or flank pain (pain in the side or back), you may have a kidney infection, and fosfomycin may not be the appropriate treatment.

It is also vital to complete the diagnostic process. Your healthcare provider will likely ask for a urine sample to confirm the presence of bacteria and to ensure the bacteria are susceptible to fosfomycin. Using antibiotics when they are not needed increases the risk of developing drug-resistant infections later.

No FDA black box warnings for Fosfomycin. This medication has a well-established safety profile for its specific single-dose indication.

Allergic Reactions / Anaphylaxis Risk

Patients with a known hypersensitivity to fosfomycin or any of the inactive ingredients in the sachet should not take this medication. Allergic reactions can range from mild rashes to life-threatening anaphylaxis. If you have ever had an allergic reaction to any antibiotic, discuss this with your doctor before taking fosfomycin.

Superinfection Risk

As with any antibiotic, the use of fosfomycin may result in the overgrowth of non-susceptible organisms, including fungi (yeast). If the infection does not improve or if new symptoms appear, a different type of microbe may be responsible.

Clostridioides difficile (C. diff) Warning

Diarrhea is a common side effect, but if it becomes severe, watery, or bloody, it could indicate a C. diff infection. This condition can range in severity from mild diarrhea to fatal colitis. It occurs because the antibiotic changes the natural flora of the colon. This can happen during treatment or up to two months after the dose.

Because fosfomycin is a single-dose treatment, intensive long-term monitoring (like regular blood draws) is usually not required for healthy individuals. However, the following may be necessary:

• Urine Culture: If symptoms persist or return within a few weeks, your doctor may perform a follow-up urine culture to see if the bacteria were fully eradicated or if a new infection has started.
• Renal Function: In patients with known kidney disease, a baseline creatinine clearance test is important to ensure the drug will be effective.

Fosfomycin can cause dizziness or drowsiness in some people. While these effects are not common, you should observe how you feel after taking the dose before driving a car, riding a bike, or operating heavy machinery. If you feel lightheaded, avoid these activities until the feeling passes.

There is no direct chemical interaction between alcohol and fosfomycin. However, alcohol can dehydrate the body and irritate the bladder, which may worsen the symptoms of a UTI. Furthermore, both alcohol and fosfomycin can cause stomach upset. It is generally recommended to avoid alcohol until your UTI symptoms have completely resolved and the medication has had time to work.

Since this is a single-dose medication, 'discontinuation' is not applicable in the traditional sense. You do not need to taper off the medication. However, if you were prescribed a second dose for a specific reason (which is rare), do not stop the treatment plan without consulting your doctor.

> Important: Discuss all your medical conditions with your healthcare provider before starting Fosfomycin, especially if you have a history of severe allergies, kidney problems, or chronic digestive issues.

There are currently no drugs that are strictly 'contraindicated' (forbidden) for use with fosfomycin due to direct chemical incompatibility. However, certain drugs can make fosfomycin completely ineffective, which is a clinical contraindication for the intended therapy.

Metoclopramide (Reglan)

Metoclopramide is a medication used to increase gastric motility (the speed at which the stomach empties).

• Mechanism: By speeding up the movement of the stomach and intestines, metoclopramide reduces the time fosfomycin spends in the area of the gut where it is absorbed.
• Consequence: This leads to significantly lower serum concentrations and lower urinary concentrations of fosfomycin. This may cause the antibiotic to fail in killing the bacteria in the bladder.
• Management: If you are taking metoclopramide, your doctor may suggest stopping it temporarily or choosing a different antibiotic for your UTI.

Other Motility Agents

Other drugs that increase the movement of the digestive tract, such as certain laxatives or other prokinetic drugs (e.g., erythromycin used for gastroparesis), may have a similar effect to metoclopramide, though they have been less extensively studied.

Oral Contraceptives (Birth Control Pills)

While the specific interaction between fosfomycin and oral contraceptives is considered low-risk compared to other antibiotics like rifampin, some antibiotics can theoretically disrupt the gut bacteria that help the body reabsorb estrogen.

• Consequence: There is a very small theoretical risk of reduced contraceptive efficacy.
• Management: While most experts agree a single dose of fosfomycin is unlikely to cause birth control failure, some healthcare providers recommend using a backup method of contraception (like condoms) for the remainder of your cycle just to be safe.

Oral Typhoid Vaccine

Antibiotics can kill the live bacteria in the oral typhoid vaccine, making the vaccine ineffective.

• Management: You should generally wait at least 3 days after your last dose of an antibiotic before taking the oral typhoid vaccine.

• High-Fat Meals: As noted in the pharmacokinetic section, food can slow down the absorption of fosfomycin and reduce the peak amount that reaches your system by about 30%.
• Management: For the best results, take fosfomycin on an empty stomach. If you must eat, wait at least 2 hours after a meal before taking the medication.

There are no well-documented interactions between fosfomycin and common herbal supplements like St. John's Wort or Ginkgo Biloba. However, because fosfomycin works in the urinary tract, some patients take it alongside Cranberry supplements or D-Mannose.

• Clinical Context: There is no evidence that these interfere with fosfomycin; in fact, they may provide complementary support for urinary health, but they should not replace the antibiotic treatment.

Fosfomycin does not typically interfere with common blood tests or chemistry panels. However, it will obviously affect the results of a Urine Culture. If a culture is taken while the drug is still in your system (up to 3 days after the dose), it may show 'no growth' even if the infection hasn't been fully cleared, because the drug in the urine sample will kill the bacteria in the lab dish.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter medications like antacids should be mentioned, as they can occasionally affect how drugs are absorbed.

Fosfomycin must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity: If you have had a documented severe allergic reaction (anaphylaxis, Stevens-Johnson Syndrome, or severe hives) to fosfomycin tromethamine, you must not take this drug. The mechanism is an immune-mediated response that could be fatal upon re-exposure.
2. 2Severe Renal Impairment: Patients with a creatinine clearance of less than 10 mL/min should not use fosfomycin for UTIs.

• Why: The drug's therapeutic effect depends entirely on its ability to be filtered by the kidneys into the urine. In severe renal failure, the drug stays in the blood and never reaches the bladder in high enough amounts to kill the bacteria. This results in treatment failure and potential systemic toxicity.

1. 1Pyelonephritis: Fosfomycin is not indicated for kidney infections.

• Why: The drug does not achieve high enough or consistent enough concentrations in the kidney tissue itself to treat a deep-seated tissue infection; it is primarily effective for 'surface' infections of the bladder lining.

These are conditions where the drug should be used only if the benefits clearly outweigh the risks:

• Pregnancy (Late Term): While generally safe, any medication use in pregnancy requires careful evaluation by an OB/GYN.
• Chronic Diarrhea or Malabsorption Syndromes: If a patient has a condition that causes food and medicine to move through the gut too quickly (like Crohn's disease or a recent gastric bypass), the single dose of fosfomycin may not be absorbed well enough to work.
• Children under 12: Due to a lack of clinical data, use in this age group is generally avoided unless no other options exist and a specialist recommends it.

Because fosfomycin is in a chemical class of its own (phosphonic acid derivatives), there is no known cross-sensitivity with other major antibiotic groups. This means that if you are allergic to penicillin, sulfa drugs, or cephalosporins, you can typically take fosfomycin safely. This makes it an excellent alternative for patients with multiple drug allergies.

> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and allergy profile, before prescribing Fosfomycin.

Fosfomycin is classified as Pregnancy Category B (under the older FDA system). This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.

• Trimester-Specific Risks: Data from use in pregnant women have not identified any drug-associated risks of major birth defects or miscarriage. In fact, fosfomycin is often used for asymptomatic bacteriuria in pregnancy because it is a single dose and avoids prolonged drug exposure.
• Clinical Recommendation: It should be used during pregnancy only if clearly needed and prescribed by a doctor who has weighed the risks and benefits.

Fosfomycin is excreted in human milk, but at very low levels.

• Risk-Benefit: A single dose is unlikely to cause any harm to a nursing infant. However, there is a theoretical risk that the drug could slightly alter the infant's gut flora or cause a minor skin rash.
• Recommendation: Many experts suggest that breastfeeding can continue, but the infant should be monitored for diarrhea or diaper rash. Consult your pediatrician before taking the dose.

• Approved Age: Fosfomycin is approved for female adolescents 12 years and older for uncomplicated cystitis.
• Safety: In clinical trials, the safety profile in adolescents was similar to that seen in adults.
• Non-Approved Use: It is not approved for males under 18 or for any children under 12. The concern in younger children is primarily the lack of dosing data and the risk of not treating a potential kidney infection (which is more common in young children with UTIs) effectively.

In clinical studies, no overall differences in safety or effectiveness were observed between older (65+) and younger patients.

• Renal Clearance: Because elderly patients are more likely to have decreased kidney function, doctors should check renal status. If the patient has severe kidney failure, the drug will not work.
• Polypharmacy: Older adults often take more medications; however, since fosfomycin has few drug interactions, it is often a safe choice for seniors who are on multiple other drugs for heart disease or diabetes.

• Mild to Moderate: No dosage adjustment is needed for a single 3-gram dose.
• Severe (CrCl < 10 mL/min): Use is not recommended.
• Dialysis: Fosfomycin is removed by hemodialysis. If it must be used, it should be administered after a dialysis session, though it is rarely the first choice for these patients.

Since the liver is not involved in the metabolism or clearance of fosfomycin, patients with liver cirrhosis or other hepatic issues can take the standard dose without any adjustments.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing.

Fosfomycin is a bactericidal antibiotic with a unique molecular target. It acts as an analog of phosphoenolpyruvate (PEP). It covalently binds to a cysteine residue in the active site of the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).

This enzyme is responsible for catalyzing the first committed step in bacterial cell wall synthesis: the transfer of the enolpyruvate moiety from PEP to UDP-N-acetylglucosamine. By blocking this enzyme, fosfomycin prevents the formation of UDP-N-acetylmuramic acid, a precursor to peptidoglycan. Without peptidoglycan, the bacterial cell wall becomes unstable, leading to bacterial cell lysis (bursting) and death.

• Dose-Response: Fosfomycin exhibits time-dependent killing against some organisms and concentration-dependent killing against others. In the context of a UTI, the goal is to maintain the concentration in the urine above the Minimum Inhibitory Concentration (MIC) for as long as possible.
• Post-Antibiotic Effect (PAE): Fosfomycin demonstrates a significant PAE, meaning it continues to suppress bacterial growth even after the levels of the drug fall below the MIC.
• Resistance: Resistance can occur through mutations in the bacterial transport systems (GlpT and UhpT) that bring the drug into the cell, or through the production of fosfomycin-modifying enzymes (FosA, FosB, FosC).

| Parameter | Value |

|---|---|

| Bioavailability | 37% - 40% (Oral) |

| Protein Binding | 0% |

| Half-life | 5.7 hours (Plasma) |

| Tmax | 2 hours |

| Metabolism | None (Not metabolized) |

| Excretion | Renal 38%, Fecal 18% |

• Molecular Formula: C3H7O4P (Fosfomycin base)
• Molecular Weight: 138.06 g/mol (Base); 259.2 g/mol (Tromethamine salt)
• Solubility: Highly soluble in water.
• Description: It is a low-molecular-weight epoxide derivative. The tromethamine salt form is used to improve stability and absorption in the oral formulation.

Fosfomycin is the only member of the phosphonic acid class of antibiotics currently used in clinical practice. It is distinct from all other antibiotic classes, which is why it often remains effective against 'superbugs' that have developed resistance to more common drugs.